08/25/2014 - 11:56am

ViiV Healthcare announced that the Food and Drug Administration has approved Triumeq (abacavir 600 mg, dolutegravir 50 mg and lamivudine 300 mg) tablets for the treatment of HIV-1 infection.

08/25/2014 - 10:05am

With the National Association of Chain Drug Stores Total Store Expo currently underway in Boston, the Boston Globe published an op-ed in its opinion section, Podium, which was co-authored by Steven Anderson, president and CEO of NACDS and Michael Malloy, PharmD and dean of the MCPHS University School of Pharmacy - Worcester/Manchester.

08/24/2014 - 7:03pm

“A drug store is not just for sick individuals. It’s the place to come to showcase wellness and promote health.”

08/22/2014 - 2:59pm

The FBI has warned healthcare companies that hackers are targeting them and patient records, according to a flash alert the agency sent out earlier this week. 

08/22/2014 - 9:27am

The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.

08/21/2014 - 5:18pm

The Food and Drug Administration cleared South Korean company Philosys’ Gmate blood-sugar monitoring device for U.S. marketing on Aug. 15.

08/21/2014 - 4:35pm

The Centers for Disease Control and Prevention has announced recommendations of the Advisory Committee on Immunization Practices for the 2014-15 influenza season.

08/21/2014 - 1:48pm

GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.

08/21/2014 - 10:59am

Restricting access to samples of generic biological drugs would lead to nearly $140 million in lost savings for every $1 billion in biologics sales, Matrix Global Advisors said.